Product Information

FELBAMATE 400 MG TABLET is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.7265 per EA under NDC 62559073001. Its NADAC has been published 393 times since Feb 13, 2019.

FDA first approved this application on Nov 4, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

FELBAMATE 400 MG TABLET

Felbamate
$0.7265per EA

Strength

400 mg/1

NDC

62559073001

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

FELBAMATE

Approval Type

Generic (ANDA)

FDA Application

ANDA202284

FDA Approved

11/4/2015

TE Code

AB

On Market Since

9/4/2018

Pharmacological Classes

Anti-epileptic Agent
Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for FELBAMATE 400 MG TABLET has been published 393 times since Feb 13, 2019, and over the history we have for it it has declined 72.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.7265 per EA
All-time high$3.2846 (Oct 16, 2019)
All-time low$0.6785 (Jul 22, 2026)
52-week high$1.0316
52-week low$0.6785
Median price$1.1756
Average price$1.6244
Largest weekly change-59.2% (Oct 21, 2020)
Weeks tracked393
Tracking sinceFeb 13, 2019

Price History

1W

+7.1%

1M

+7.1%

3M

-9.9%

6M

-28.7%

1Y

-17.6%

3Y

-26.6%

5Y

-60.2%

All

-72.0%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of FELBAMATE 400 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for FELBAMATE 400 MG TABLET, manufactured by ANI Pharmaceuticals, Inc., is $0.7265 per EA (NDC 62559073001), effective Aug 19, 2026.

How has the price of FELBAMATE 400 MG TABLET changed over time?

Over the history we have for it, the NADAC for FELBAMATE 400 MG TABLET has declined 72.0%. It has been tracked across 393 weekly CMS publications since Feb 13, 2019.

What are the highest and lowest recorded NADAC prices for FELBAMATE 400 MG TABLET?

Since Feb 13, 2019, the NADAC for FELBAMATE 400 MG TABLET has ranged from a low of $0.6785 (Jul 22, 2026) to a high of $3.2846 (Oct 16, 2019), with a median of $1.1756 per EA.

Are there cheaper alternatives to FELBAMATE 400 MG TABLET?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FELBAMATE 400 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures FELBAMATE 400 MG TABLET?

FELBAMATE 400 MG TABLET (NDC 62559073001) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.